Workflow
Biomedical Research
icon
Search documents
Cuprina Provides Update on Research Studies with Three Leading Education Institutes
Globenewswire· 2025-06-30 12:00
SINGAPORE, June 30, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) ("Cuprina" or "the Company"), a biomedical and biotechnology company dedicated to the development and commercialization of products for the management of chronic wounds and infertility, as well as cosmeceuticals for the health and beauty sector, today provided an update on progress achieved in relation to three studies carried out with institutes of higher learning. The studies, each one year in length, were aimed ...
对谈斯坦福 Biomni 作者黄柯鑫:AI Scientist 领域将出现 Cursor 级别的机会|Best Minds
海外独角兽· 2025-06-20 11:18
嘉宾:黄柯鑫 访谈:Penny、Cage 随着语言模型在强化学习和 agentic 领域的进步,agent 正在从通用领域快速渗透到垂直领域,科学和生物医药这类高价值领域尤其受到关注。如 果说 AlphaFold 在 foundation model 层面是生命科学的重要里程碑,AI scientist 就是在 agent 层面,能够给科研带来和 alphafold 同样重要的影响。 今年 5 月,前谷歌 CEO Eric Schmidt 投资的 AI lab FutureHouse 推出了四款 AI scientist agent,一个月后,他们又宣布自己的 AI 系统 Robin 成功发 现了新药。两天前,OpenAI 也发布博客强调 AI 在生物学领域的能力正在不断增强。AI scientist 已经在改写科研和药物开发范式。 随着 multi-agent 技术的发展,AI 可能不再只是"工具箱",而是能自主完成跨学科复杂研究,从而推动科学发现走向全新模式。 最近,斯坦福大学也发布了一个生物医学通用 agent Biomni,Biomni 搭建了一个适合 agent 的环境,通过整合不同的工具、数据库、 ...
Cell Stem Cell:刘鹏/陈晓芳/杨帆团队开发类器官共培养模型,用于探究肺癌的系统性抗肿瘤免疫
生物世界· 2025-06-13 04:04
撰文丨王聪 编辑丨王多鱼 排版丨水成文 通过构建一组肺癌患者队列,研究团队证明了在抗 PD-1 (αPD1) 治疗下 GLI 模型的响应能够精确反映相 应患者的免疫治疗结果。 此外,研究团队通过功能多组学分析, 在 GLI 模型中剖析了由外周血单个核细胞 (PBMC) 来源的 T 细胞 介导的各种肿瘤免疫过程,并对具有效应记忆样表型 (GNLY + CD44 + CD9 + ) 的循环肿瘤反应性 T 细胞 进行了表征,将其作为免疫治疗效果的潜在指标。 破译 肿瘤微环境 和 系统免疫宏观环境 之间的相互作用,对于开发更有效的癌症诊断和治疗策略至关重要。 2025 年 6 月 12 日,清华大学生物医学工程学院 刘鹏 副教授、 北京航空航天 大学生物与医学工程学院 陈晓芳 副教授、 北京大学人民医院 杨帆 教授团队合作,在 Cell 子刊 Cell Stem Cell 上发表了题为 : An organoid co-culture model for probing systemic anti-tumor immunity in lung cancer 的研究论文。 该研究开发了一种 类器官共培养模型—— 凝胶- ...
Standard BioTools to Host Inaugural “Proteomics Roundtable” Webcast Series
Globenewswire· 2025-05-30 11:00
Featuring top researchers and industry experts using high-throughput proteomics to drive breakthroughs in population health, translational research and clinical developmentSOUTH SAN FRANCISCO, Calif., May 30, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) today announced the launch of its inaugural Proteomics Roundtable Series – a program of virtual events designed to spark conversation about the rapidly evolving field of proteomics. The series will spotlight thought leaders and industry expe ...
Nautilus Biotechnology(NAUT) - 2025 Q1 - Earnings Call Transcript
2025-04-29 13:32
Nautilus Biotechnology (NAUT) Q1 2025 Earnings Call April 29, 2025 08:30 AM ET Company Participants Ji-Yon Yi - Vice PresidentSujal Patel - Co-Founder, CEO & DirectorParag Mallick - Co-Founder, Chief Scientist & DirectorAnna Mowry - Chief Financial OfficerElizabeth Koslosky - Global Investment Research AssociateThomas VonDerVellen - Equity Research Associate Conference Call Participants Jason Lai - Analyst Operator Good day, and thank you for standing by. Welcome to the Nautilus First Quarter twenty twenty ...
Nautilus Biotechnology(NAUT) - 2025 Q1 - Earnings Call Transcript
2025-04-29 13:32
Nautilus Biotechnology (NAUT) Q1 2025 Earnings Call April 29, 2025 08:30 AM ET Company Participants Ji-Yon Yi - Vice PresidentSujal Patel - Co-Founder, CEO & DirectorParag Mallick - Co-Founder, Chief Scientist & DirectorAnna Mowry - Chief Financial OfficerElizabeth Koslosky - Global Investment Research AssociateThomas VonDerVellen - Equity Research Associate Conference Call Participants Jason Lai - Analyst Operator Good day, and thank you for standing by. Welcome to the Nautilus First Quarter twenty twenty ...